Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Change in Inventory (2016 - 2026)

Cytosorbents filings provide 15 years of Change in Inventory readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Change in Inventory rose 472.62% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 million, a 608.0% increase, with the full-year FY2025 number at $2.5 million, up 608.0% from a year prior.
  • Change in Inventory hit $1.3 million in Q4 2025 for Cytosorbents, up from $322000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.3 million in Q4 2025 to a low of -$1.7 million in Q1 2023.
  • Median Change in Inventory over the past 5 years was $309631.5 (2023), compared with a mean of $163096.1.
  • Biggest five-year swings in Change in Inventory: soared 535820.97% in 2021 and later plummeted 311.17% in 2023.
  • Cytosorbents' Change in Inventory stood at $251496.0 in 2021, then tumbled by 293.21% to -$485918.0 in 2022, then skyrocketed by 159.38% to $288549.0 in 2023, then plummeted by 220.26% to -$347000.0 in 2024, then surged by 472.62% to $1.3 million in 2025.
  • The last three reported values for Change in Inventory were $1.3 million (Q4 2025), $322000.0 (Q3 2025), and $726198.0 (Q2 2025) per Business Quant data.